SEC Form 4/A · accession 0001622769-26-000006
OnKure Therapeutics, Inc. · OKUR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Isaac Manke
Director
Period of report
Aug 7, 2026
Accepted (ET)
Aug 13, 2026 · 4:55 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001637715
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $18.20 | holding | — | — | — | — | Oct 3, 2034 | Class A Common Stock | 15,300 | 15,300 | D |
Explanation of responses
- F1The original Form 4, filed August 11, 2026, reported the disposition on August 7, 2026 of an option to purchase 15,300 shares of Class A Common Stock (the "Disposition"), and a corresponding acquisition of an option to purchase 15,300 shares of Class A Common Stock (the "Acquisition"), each in connection with an Option Repricing, as defined in footnote 3 of the original Form 4. The Disposition and Acquisition did not occur.
- F21/36th of the shares subject to the option vested on November 4, 2024 and 1/36th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.